SCHEMBL29623600

SCHEMBL29623600

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1O[C@H]1CC[C@@H](N(C)C(C)=O)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.70
ERBB2 P04626 7/20 0.68
KDR P35968 4/20 0.65
EPHB4 P54760 3/20 0.65
AURKA O14965 1/20 0.65
INSR P06213 1/20 0.65
FBP1 P09467 1/20 0.65
PDGFRB P09619 1/20 0.65
FLT4 P35916 1/20 0.65
CLK1 P49759 1/20 0.65
TEK Q02763 1/20 0.65
AURKB Q96GD4 1/20 0.65
EPHA2 P29317 2/20 0.62
HDAC3 O15379 2/20 0.59
HDAC4 P56524 2/20 0.59
HDAC1 Q13547 2/20 0.59
HDAC7 Q8WUI4 2/20 0.59
HDAC2 Q92769 2/20 0.59
HDAC10 Q969S8 2/20 0.59
HDAC11 Q96DB2 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169433 1.00 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL208516 1.00 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL1919780 0.96 ERBB2 (0.65) EGFRERBB2KDREPHB4AURKA
SCHEMBL2781493 0.94 EGFR (0.63) EGFRERBB2KDREPHB4AURKA
SCHEMBL375151 0.94 EGFR (0.63) EGFRERBB2KDREPHB4AURKA
SCHEMBL14489893 0.94 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL1446383 0.94 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL1446382 0.94 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL14489890 0.94 EGFR (0.70) EGFRERBB2KDREPHB4AURKA
SCHEMBL4781069 0.93 FBP1 (0.67) EGFRERBB2FBP1ERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110840847-B Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases 沃泰克斯药物股份有限公司 2022-07-29 CN disclosed
CN-110713489-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-05-31 CN disclosed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN disclosed